NIVF
Income statement / Annual
Last year (2023), NewGenIvf Group Limited's total revenue was $5.14 M,
a decrease of 13.59% from the previous year.
In 2023, NewGenIvf Group Limited's net income was -$690,851.00.
See NewGenIvf Group Limited,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
Operating Revenue |
$5.14 M |
$5.94 M |
$4.12 M |
Cost of Revenue |
$3.45 M
|
$4.41 M
|
$3.09 M
|
Gross Profit |
$1.68 M
|
$1.54 M
|
$1.02 M
|
Gross Profit Ratio |
0.33
|
0.26
|
0.25
|
Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
General & Administrative Expenses |
$1.62 M
|
$1.10 M
|
$801,329.00
|
Selling & Marketing Expenses |
$18,030.00
|
$36,194.00
|
$24,693.00
|
Selling, General & Administrative Expenses |
$1.64 M
|
$504,907.00
|
$826,022.00
|
Other Expenses |
$0.00
|
$23,019.00
|
$45,652.00
|
Operating Expenses |
$1.64 M
|
$504,907.00
|
$826,022.00
|
Cost And Expenses |
$5.09 M
|
$504,907.00
|
$3.92 M
|
Interest Income |
$518.00
|
$21.00
|
$63.00
|
Interest Expense |
$46,179.00
|
$77,757.00
|
$88,289.00
|
Depreciation & Amortization |
$229,708.00
|
$303,944.00
|
$342,539.00
|
EBITDA |
$384,305.00 |
-$504,909.00 |
$587,012.00 |
EBITDA Ratio |
0.07
|
-0.08
|
0.14
|
Operating Income Ratio |
0.01
|
-0.08
|
0.05
|
Total Other Income/Expenses Net |
-$733,093.00
|
-$54,717.00
|
-$42,574.00
|
Income Before Tax |
-$690,851.00
|
$500,650.00
|
$156,184.00
|
Income Before Tax Ratio |
-0.13
|
0.08
|
0.04
|
Income Tax Expense |
-$799,269.00
|
$208,141.00
|
$294,716.00
|
Net Income |
-$690,851.00
|
$458,667.00
|
-$533.00
|
Net Income Ratio |
-0.13
|
0.08
|
-0
|
EPS |
-0.13 |
0.0646 |
-0.0001 |
EPS Diluted |
-0.13 |
0.0646 |
-0.0001 |
Weighted Average Shares Out |
$5.43 M
|
$7.75 M
|
$10.15 M
|
Weighted Average Shares Out Diluted |
$5.43 M
|
$7.75 M
|
$10.15 M
|
Link |
|
|
|